Our finding that ZNRF3 loss or low ZNRF3 RNA abundance is associated with upregulation of cell cycle progression pathways further supports a model whereby WNT activation may promote aggressive disease in mitotically active cancers. The gene discussed is ZNRF3; the disease is cancer.